{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:29:48Z","timestamp":1781303388408,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["720694"],"award-info":[{"award-number":["720694"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jconrel.2022.11.008","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T18:14:25Z","timestamp":1668622465000},"page":"994-1008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Bioelectronic cell-based device provides a strategy for the treatment of the experimental model of multiple sclerosis"],"prefix":"10.1016","volume":"352","author":[{"given":"Emilie","family":"Audouard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Pierroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rousselot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrix","family":"Gillet-Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Dufayet-Chauffaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Buchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Florea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Khel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilya","family":"Altynbekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Delgaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Encarna","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra Ben Aissa","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Folcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.11.008_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.omtm.2018.10.003","article-title":"Challenges in advanced therapy medicinal product development: a survey among companies in Europe","volume":"11","author":"Ten Ham","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.copbio.2019.02.023","article-title":"From synthetic biology to human therapy: engineered mammalian cells","volume":"58","author":"Scheller","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0015","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.5966\/sctm.2015-0079","article-title":"Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo","volume":"4","author":"Agulnick","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0020","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.aau7187","article-title":"Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice","volume":"368","author":"Krawczyk","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2018.04.018","article-title":"Cell encapsulation: overcoming barriers in cell transplantation in diabetes and beyond","volume":"139","author":"Farina","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0030","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1073\/pnas.1514383113","article-title":"Synthetic gene network restoring endogenous pituitary-thyroid feedback control in experimental Graves\u2019 disease","volume":"113","author":"Saxena","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.copbio.2017.06.004","article-title":"Synthetic biology-inspired therapies for metabolic diseases","volume":"47","author":"Teixeira","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0040","doi-asserted-by":"crossref","first-page":"41501","DOI":"10.1074\/jbc.M110.177600","article-title":"Natural and engineered photoactivated nucleotidyl cyclases for optogenetic applications","volume":"285","author":"Ryu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0045","series-title":"Photoactivatable Nucleotide Cyclases for Synthetic Photobiology Applications","author":"Folcher","year":"2017"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0050","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1038\/ncomms6392","article-title":"Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant","volume":"5","author":"Folcher","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2298","article-title":"Smartphone-controlled optogenetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice","volume":"9","author":"Shao","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0060","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.biomaterials.2013.09.071","article-title":"A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells","volume":"35","author":"Lathuiliere","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0065","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/brain\/aww036","article-title":"A subcutaneous cellular implant for passive immunization against amyloid-beta reduces brain amyloid and tau pathologies","volume":"139","author":"Lathuiliere","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0070","doi-asserted-by":"crossref","DOI":"10.1177\/2041731416638198","article-title":"Three-dimensional printed polymeric system to encapsulate human mesenchymal stem cells differentiated into islet-like insulin-producing aggregates for diabetes treatment","volume":"7","author":"Sabek","year":"2016","journal-title":"J Tissue Eng"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0075","article-title":"Additive manufacturing processes in medical applications","volume":"14","author":"Salmi","year":"2021","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0080","first-page":"729","article-title":"A review of 3D printing technology for medical applications","volume":"4","author":"Yan","year":"2018","journal-title":"Engineering-Prc"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pbj.2017.07.001","article-title":"Optogenerapy: when bio-electronic implant enters the modern syringe era","volume":"2","author":"Michel","year":"2017","journal-title":"Porto Biomed. J."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202001903","article-title":"Devising materials manufacturing toward lab-to-fab translation of flexible electronics","volume":"32","author":"Luo","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0095","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1186\/s13063-020-04864-4","article-title":"Interferon beta-1a (IFNbeta-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial","volume":"21","author":"Bosi","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0105","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis","volume":"352","author":"PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0110","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s12325-014-0149-1","article-title":"Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis","volume":"31","author":"Marziniak","year":"2014","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0115","first-page":"29","article-title":"Re-evaluating the use of IFN-beta and relapsing multiple sclerosis: safety, efficacy and place in therapy","volume":"10","author":"Goldschmidt","year":"2020","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"1","key":"10.1016\/j.jconrel.2022.11.008_bb0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40273-021-01081-y","article-title":"The potential cost-effectiveness of a cell-based bioelectronic implantable device delivering interferon beta 1a therapy versus injectable interferon beta 1a treatment in relapsing-remitting multiple sclerosis","volume":"40","author":"Visser","year":"2022","journal-title":"PharmacoEconomics."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0125","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1021\/acs.molpharmaceut.6b01093","article-title":"Amelioration of experimental autoimmune encephalomyelitis in mice by interferon-Beta gene therapy, using a long-term expression plasmid vector","volume":"14","author":"Hamana","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.molcel.2007.04.022","article-title":"Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer","volume":"26","author":"Escalante","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jbm4.10050","article-title":"Molecular phenotyping of Telomerized human bone marrow skeletal stem cells reveals a genetic program of enhanced proliferation and maintenance of differentiation responses","volume":"2","author":"Twine","year":"2018","journal-title":"JBMR Plus"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0145","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1021\/sb400182x","article-title":"Near-infrared light responsive synthetic c-di-GMP module for optogenetic applications","volume":"3","author":"Ryu","year":"2014","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0150","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4049\/jimmunol.1004143","article-title":"Streptococcus pneumoniae stimulates a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs","volume":"188","author":"Koppe","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000357780","article-title":"The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis","volume":"21","author":"Vazirinejad","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneuroim.2004.07.016","article-title":"Interferon-beta induces transient systemic IP-10\/CXCL10 chemokine release in patients with multiple sclerosis","volume":"156","author":"Buttmann","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111851","article-title":"NET23\/STING promotes chromatin compaction from the nuclear envelope","volume":"9","author":"Malik","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4939-7027-8_8","article-title":"Search for master regulators in walking Cancer pathways","volume":"1613","author":"Kel","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0175","doi-asserted-by":"crossref","first-page":"W541","DOI":"10.1093\/nar\/gkl342","article-title":"Composite module analyst: identification of transcription factor binding site combinations using genetic algorithm","volume":"34","author":"Waleev","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0180","first-page":"12","article-title":"Computational master-regulator search reveals mTOR and PI3K pathways responsible for low sensitivity of NCI-H292 and A427 lung cancer cell lines to cytotoxic action of p53 activator Nutlin-3","volume":"11","author":"Boyarskikh","year":"2018","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.620967","article-title":"Optimized protocol for subcutaneous implantation of encapsulated cells device and evaluation of biocompatibility","volume":"9","author":"Audouard","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0190","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41563-019-0377-5","article-title":"Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations","volume":"18","author":"Farah","year":"2019","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0195","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fncel.2018.00368","article-title":"CSF1R inhibition reduces microglia proliferation, promotes tissue preservation and improves motor recovery after spinal cord injury","volume":"12","author":"Gerber","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2045-8118-11-27","article-title":"Leukocyte infiltration across the blood-spinal cord barrier is modulated by sleep fragmentation in mice with experimental autoimmune encephalomyelitis","volume":"11","author":"He","year":"2014","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903904","article-title":"Conformable hybrid Systems for Implantable Bioelectronic Interfaces","volume":"32","author":"Fallegger","year":"2020","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.jconrel.2022.11.008_bb0210","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.drudis.2020.11.019","article-title":"Cell microencapsulation technologies for sustained drug delivery: clinical trials and companies","volume":"26","author":"Lopez-Mendez","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0215","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/14712598.6.7.717","article-title":"Application of encapsulated cell technology for retinal degenerative diseases","volume":"6","author":"Tao","year":"2006","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0220","doi-asserted-by":"crossref","DOI":"10.2337\/db18-138-OR","article-title":"Initial clinical evaluation of VC-01TM combination product-a stem cell-derived islet replacement for type 1 diabetes (T1D)","volume":"67","author":"Henry","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0225","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nbt.3033","article-title":"Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells","volume":"32","author":"Rezania","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0230","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/cgt.2011.22","article-title":"Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy","volume":"18","author":"Schwenter","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1874120700701010064","article-title":"Cultivation and differentiation of encapsulated hMSC-TERT in a disposable small-scale syringe-like fixed bed reactor","volume":"1","author":"Weber","year":"2007","journal-title":"Open Biomed Eng J"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0240","doi-asserted-by":"crossref","first-page":"126","DOI":"10.20411\/pai.v3i1.252","article-title":"Long non-coding RNA-mediated regulation of the interferon response: a new perspective on a familiar theme","volume":"3","author":"Valadkhan","year":"2018","journal-title":"Pathog Immun"},{"key":"10.1016\/j.jconrel.2022.11.008_bb0245","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/jir.2006.26.699","article-title":"Mx1 and IP-10: biomarkers to measure IFN-beta activity in mice following gene-based delivery","volume":"26","author":"Petry","year":"2006","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0250","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nbt0602-592","article-title":"Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells","volume":"20","author":"Simonsen","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0255","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.scr.2013.12.006","article-title":"Combination of immortalization and inducible death strategies to generate a human mesenchymal stromal cell line with controlled survival","volume":"12","author":"Bourgine","year":"2014","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.jconrel.2022.11.008_bb0260","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"W1","key":"10.1016\/j.jconrel.2022.11.008_bb0265","doi-asserted-by":"crossref","first-page":"w124","DOI":"10.1093\/nar\/gkac286","article-title":"BioUML-towards a universal research platform","volume":"50","author":"Kolpakov","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922007520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922007520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:43:16Z","timestamp":1759164196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922007520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":53,"alternative-id":["S0168365922007520"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.008","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioelectronic cell-based device provides a strategy for the treatment of the experimental model of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}